Zobrazeno 1 - 10
of 122
pro vyhledávání: '"C. G. Teo"'
Autor:
C G Teo
Publikováno v:
Epidemiol Infect
SUMMARYHistorical enquiry into diseases with morbidity or mortality predilections for particular demographic groups can permit clarification of their emergence, endemicity, and epidemicity. During community-wide outbreaks of hepatitis A in the pre-va
Autor:
John-Paul Tung, SL Ngui, L. J. Brant, Oliver G. Pybus, Peter V. Markov, Mary Ramsay, C. G. Teo
Publikováno v:
Journal of Medical Virology. 87:417-423
HCV strains belonging to genotype 4 may be gaining endemicity across Continental Europe but the extent of their spread in the United Kingdom is unknown. Sera referred from patients attending hospitals in England between 2004 through 2008 were charact
Autor:
Nicola Low, Charles Irish, C. G. Teo, Monique Andersson, David Carrington, Richard M. Myers, Samreen Ijaz, Matthew Hickman
Publikováno v:
Journal of Clinical Virology. 53:125-129
Background A large outbreak of hepatitis B virus (HBV) infection in the UK occurred between 2001 and 2005 in Bristol, UK. Objectives To identify HBV strains circulating amongst risk groups in the HBV outbreak cohort. Study design Cross-sectional stud
Publikováno v:
Oral Microbiology and Immunology. 24:109-115
Introduction: Studies were conducted to investigate changes in the extent of human herpesvirus 8 (HHV-8) shedding and diversity of HHV-8 strains in the mouth of a renal allograft recipient who developed cutaneous post-transplantation Kaposi’s sarco
Publikováno v:
Journal of Clinical Virology. 44:157-160
Background: Increasing data shows the relevance of HBV genotypes in the outcome of infection. Most studies investigating the relationship between the genotypic characteristics of hepatitis B virus (HBV) and the clinical or epidemiological aspects of
Autor:
C. G. Teo, S. Nunn, Mary Ramsay, Nick Andrews, N. Murphy, M. A. Balogun, A. Grant, John Parry
Publikováno v:
Epidemiology and Infection. 137:980-987
(Accepted 7 November 2008; first published online 23 December 2008)SUMMARYSurveillance reports and prevalence studies have indicated that injecting drug users (IDUs)contribute more to the hepatitis C epidemic in the United Kingdom than any other ris
Autor:
C. G. Teo
Publikováno v:
Epidemiology and Infection. 137:480-484
Inspired by the Ancient Greeks, past students of in fectious diseases have often personified in that many headed monster, Hydra, the terrifying effects of scourges such as cholera, scarlet fever, diphtheria, yellow fever and malaria [1-4]. Hercules-l
Publikováno v:
Antiviral Therapy. 13:439-448
Background The hepatitis B virus (HBV) pol gene overlaps the S gene encoding surface antigen (HBsAg). It has been reported previously that drug-induced changes in HBsAg alter its binding to sera from humans immunized against HBV. We investigate here
Autor:
R. James, Siew Lin Ngui, Savita Rangarajan, C. G. Teo, Ranjababu Kulasegaram, Andrew J. Buckton, Martin Fisher
Publikováno v:
Journal of Clinical Virology. 40:60-63
An HIV-1/hepatitis C virus (HCV) co-infected patient with haemophilia received a 48-week course of pegylated interferon-α-2b and ribavirin therapy for genotype 5a HCV infection. Virological response was achieved at week 24. At the end of treatment,
Publikováno v:
Journal of Viral Hepatitis. 14:213-220
Summary. Whether differences in the natural history of hepatitis C virus (HCV) can be explained by differences in the infecting HCV type is unknown. The aim of this study was to investigate whether the HCV type might influence the clinical outcome of